event presence logo
The (R)Evolution of CAR T-Cell Therapy

A Transformative Path from Oncology to Neurology CME

Hilton West Palm Beach
Friday, February 28, 2025 | 12:20 PM - 1:20 PM ET
Supported by an independent educational grant from Kyverna Therapeutics Inc.

overview

Do you want to learn more about the groundbreaking potential of chimeric antigen receptor (CAR) T-cell therapy in treating neurologic autoimmune diseases? Originally developed for cancer, CAR T-cell therapy is now being explored for conditions like multiple sclerosis, myasthenia gravis, and stiff-person syndrome. Join this live symposium in which experts will discuss the unmet needs in the management of these neurologic autoimmune diseases, how learnings from oncology shape the clinical development of CAR T-cell therapy, and the latest clinical experience with this innovative treatment in the field of neurology.

IMPORTANT INFO

ACTRIMS Forum 2025 registration is required to attend this independent Industry Supported Satellite Symposium or to view virtually via the ACTRIMS Forum 2025 event app.

This independent Industry Supported Satellite Symposium is not included in the ACTRIMS Forum 2025 accredited program. CE certification provided by Medscape, LLC.

Enhance Your Experience With MedChallenge!

This event features MedChallenge, a new feature from Medscape that allows you to go head-to-head against your peers in a series of medical questions. Earn points, deepen your knowledge, and fight for the top spot on the leaderboard!

faculty

MODERATOR

Bruce Cree, MD, PhD, MAS

Professor of Clinical Neurology

Weill Institute for Neurosciences

Department of Neurology

University of California San Francisco

San Francisco, California

PANELIST

Amanda L. Piquet, MD, FAAN

​Céline Dion Foundation Endowed Chair in Autoimmune Neurology

​Associate Professor of Neurology

​Director, Autoimmune Neurology Program

​University of Colorado Anschutz Medical Campus

​Aurora, Colorado​

PANELIST

Madhav R. Seshadri, MD

​Assistant Professor of Medicine

​Division of Hematology and Oncology Department of Medicine

​University of California San Francisco

​San Francisco, California​

AGENDA

12:20 pm

Welcome and Introductions

Bruce Cree, MD, PhD, MAS

12:22 pm

Why do We Need New Treatments in Neurological Autoimmune Diseases? A Quick Quiz

Bruce Cree, MD, PhD, MAS; Amanda L. Piquet, MD, FAAN

12:32 pm

Principles and Rationale for CAR T-Cell Therapy

Bruce Cree, MD, PhD, MAS

12:39 pm

From Evolution to Revolution: How Learning From Oncology Shapes the Clinical Development of CAR T in Neurology

Madhav R. Seshadri, MD

12:54 pm

The Road Ahead: Case Studies of CAR T-Cell Therapy and Patient Impact

Panel Discussion

1:19 pm

Concluding Remarks

Bruce Cree, MD, PhD, MAS
backstage pass
Enhance Your Virtual Experience With Backstage Pass! Backstage Pass provides an intimate virtual session where you can interact with faculty, address case-based questions, and facilitate relationship building.
*Video encouraged*

LOCATION

Hilton West Palm Beach

600 Okeechobee Blvd, West Palm Beach, Florida, 33401

Oceana Ballroom AB

GOAL STATEMENT

The goal of this activity is for learners to be better able to describe the mechanism of action of CAR T-cell therapy, the rationale for applying this therapy in neurological autoimmune disease, and the latest clinical trial evidence supporting the use of these therapies in these diseases.

TARGET AUDIENCE

This educational activity is intended for an international audience of neurologists managing patients with autoimmune neurological diseases.

LEARNING OBJECTIVES

Have increased knowledge regarding the [list] [item]Unmet needs in neurological autoimmune diseases [item]Mechanism of action of CAR T-cell therapy [item]Key learnings from oncology [/list] [break] Demonstrate greater confidence in their ability to [list] [item]Understand the development and implementation of CAR T-cell therapy [/list]

ACCREDITATION STATEMENT

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
accreditation logo
medscape logo
[bold]For Physicians[/bold][break] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
© 2024 MedscapeLIVE! All Rights Reserved | Medscape Education Terms of Service | Privacy Policy